Company Overview
Snapshot
Founded in January 2004, FluenTech operates with 1–10 employees. The company focuses on developing rehabilitative and assistive technologies for speech impediments, holding a patent for its fluency-shaping software.
Business overview
FluenTech develops and commercializes rehabilitative and assistive technologies designed for individuals with speech impediments. Its core product, Dr. Fluency, is a PC-based therapy solution that incorporates patented fluency-shaping software and a comprehensive online home-based patient training service. This solution enables users to practice daily to maintain speech volubility and fluency, serving the digital healthcare and digital therapeutics markets.
Log in to access full profile ›Company Intelligence Q&A
- What is FluenTech's primary focus?
- FluenTech specializes in developing and commercializing rehabilitative and assistive technologies designed for individuals with speech impediments.
- What is the Dr. Fluency software?
- Dr. Fluency is a PC-based therapy solution developed by FluenTech for people who stutter. It incorporates patented fluency-shaping software and an online home-based patient training service.
- What problem does FluenTech aim to solve?
- FluenTech aims to help individuals who stutter by providing tools and training to preserve and improve their speech volubility and fluency through everyday practice.
- In which sectors does FluenTech operate?
- FluenTech operates within the Health Tech & Life Sciences sector, specifically focusing on Digital Healthcare and Digital Therapeutics.
- Does FluenTech hold any patents?
- Yes, FluenTech holds a patent related to its fluency-shaping software, which is integrated into its Dr. Fluency solution.